These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7030972)

  • 1. Clinical pharmacology of antiarrhythmic drugs: a review and overview, Part III.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):239-48. PubMed ID: 7030972
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations of present drug therapy of cardiac arrhythmias--a review.
    Jewitt DE
    Postgrad Med J; 1977; 53 Suppl 1():12-21. PubMed ID: 17855
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bretylium tosylate. A new anti-arrhythmia drug. Review].
    Arriaga Gracia J; Scampardonis G; Alexandrides K; González Hermosillo JA
    Arch Inst Cardiol Mex; 1972; 42(4):629-34. PubMed ID: 5073709
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bretylium tosylate, a new original anti-arrhythmic agent].
    Warembourg H; Vermeersch M; Pauchant M; Ducloux G; Delebecque H
    Lille Med; 1972 Feb; 17(2):201-4. PubMed ID: 5038050
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic drug therapy.
    Stanford JL; Felner JM; Arensberg D
    Am J Nurs; 1980 Jul; 80(7):1288-95. PubMed ID: 6901576
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha D
    Am J Cardiol; 1997 Oct; 80(8A):16G-23G. PubMed ID: 9354408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for cardiac arrhythmias. II.
    Br Med J; 1969 Aug; 3(5668):458-9. PubMed ID: 4390280
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of old and new antiarrhythmic drugs.
    Nattel S; Zipes DP
    Cardiovasc Clin; 1980; 11(1):221-48. PubMed ID: 7002302
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):139-51. PubMed ID: 7263102
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bretylium tosylate as an antiarrhythmic agent].
    Borkowski PJ
    Kardiol Pol; 1970; 13(2):195-8. PubMed ID: 5433233
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium.
    Levitt B; Borer JS; Sarapa A
    Cardiovasc Nurs; 1974; 10(6):27-31. PubMed ID: 4498549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical pharmacology of antiarrhythmic drugs].
    Ambrosioni E
    G Clin Med; 1973 Jul; 54(7):407-28. PubMed ID: 4779854
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of antiarrhythmic drugs.
    Crumpley L; Rinkenberger RL
    Crit Care Nurse; 1983; 3(4):57-63. PubMed ID: 6554173
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiarrhythmic drugs.
    Campbell RW
    Practitioner; 1981 Oct; 225(1360):1445-9. PubMed ID: 7329933
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer antiarrhythmic drugs.
    Hess D
    West J Med; 1981 Apr; 134(4):333-41. PubMed ID: 6787808
    [No Abstract]   [Full Text] [Related]  

  • 19. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bretylium, a Class III Antiarrhythmic, Returns to the Market.
    Thind M; Sullivan RM; Williams RN; Kowey PR
    Am J Cardiol; 2020 Oct; 133():77-80. PubMed ID: 32843146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.